Soin Neuroscience, a biotechnology company based in Dayton, OH, has developed a new spinal cord stimulation device to treat chronic pain. The company has recently started early stage human proof of concept studies. Dr Amol Soin, the founder and CEO of Soin Neuroscience, said “We are excited to start a new program to treat patients suffering from chronic pain. As we embark on our journey of science, learning and development, we believe there may be some significant advantages to our device over the current standard.”
Click here to read the complete news release.
News release excerpt provided by PR Newswire.
Originally published January 22, 2020.